A couple of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made huge purchases on Monday. Altogether, these funds bought over 420,000 shares of UiPath Inc. (NYSE: PATH), as the price of these ETFs dropped around 1% on Monday. Note that the funds are still up handily in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 149,800 shares of UiPath and ARK Innovation ETF (NYSEARCA: ARKK) bought 273,476 shares. At Monday’s closing price, this would have valued these purchases at roughly $28.1 million. Even though this is a small fraction of the total holdings, every little bit counts. ARKG is up about 60% and ARKK is up 57% in the past year.
Check out all of ARK Invest’s buys for Monday:
Fund | Ticker | Company | Shares |
---|---|---|---|
ARKF | FTCH | Farfetch | 75,608 |
ARKG | VERV | Verve Therapeutics | 24,634 |
ARKG | SGFY | Signify Health | 9,412 |
ARKG | PATH | UiPath | 149,800 |
ARKG | RXRX | Recursion Pharmaceuticals | 22,859 |
ARKG | RPTX | Repare Therapeutics | 29,219 |
ARKK | PATH | UiPath | 273,476 |
ARKQ | KTOS | Kratos Defense & Security Solutions | 22,828 |
ARKW | SPOT | Spotify Technology | 9,058 |
ARKW | KVSB | Khosla Ventures Acquisition II | 110,200 |
ARKW | DKNG | DraftKings | 137,133 |
ARKW | COIN | Coinbase Global | 22,406 |
ARKW | CND | Concord Acquisition | 3,800 |
ARKW | ZM | Zoom Video Communications | 48,400 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.